• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Up 0.37%

    Peregrine Pharmaceuticals, Inc. (PPHM)

    -NasdaqCM
    1.25 Up 0.01(0.40%) 11:54AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:1.25
    Open:1.25
    Bid:1.25 x 14000
    Ask:1.26 x 21200
    1y Target Est:4.17
    Beta:1.81
    Earnings Date:Sep 8 - Sep 14 (Est.)
    Day's Range:1.24 - 1.27
    52wk Range:1.19 - 1.75
    Volume:119,992
    Avg Vol (3m):1,182,660
    Market Cap:250.92M
    P/E (ttm):N/A
    EPS (ttm):-0.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PPHM

    Comparison

    Symbol% ChgMkt Cap
    PPHMUp 0.40%250.92M
    AMGNUp 3.87%135.59B
    NVSUp 1.14%252.05B
    RHHBYUp 0.58%246.93B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.33
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Apr-16) :-0.32
    Quarterly EPS Est (Jul-15) :-0.08
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops monoclonal antibodies for the treatment and diagnosis of cancer in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback